How should I evaluate and initially manage a middle‑aged woman with suspected recurrent supraventricular tachycardia and premature atrial or ventricular extrasystoles on ECG?

Initial Evaluation and Management

For a middle-aged woman with suspected recurrent SVT and extrasystoles on ECG, obtain a 12-lead ECG during symptoms (or ambulatory monitoring if not currently symptomatic), assess for structural heart disease with echocardiography, and refer for catheter ablation as first-line definitive therapy given the recurrent nature. 1

Diagnostic Approach

Confirm the Diagnosis

• Capture the arrhythmia on ECG: The presence of extrasystoles on resting ECG suggests arrhythmic substrate, but you need documentation of the actual tachycardia to confirm SVT 2

  • If not currently symptomatic: Use ambulatory monitoring (Holter or event monitor) to capture episodes
  • During an episode: Obtain 12-lead ECG before any intervention

• Look for specific ECG features:

  • Regular narrow-complex tachycardia (most common presentation)
  • Pseudo r' deflections in V1 or pseudo S waves in inferior leads suggest AVNRT 3
  • Check for pre-excitation (delta waves) in sinus rhythm—critical to identify Wolff-Parkinson-White syndrome 1
  • Long RP' intervals suggest atypical AVNRT or atrial tachycardia 4

Rule Out Structural Heart Disease

• Transthoracic echocardiography is mandatory to exclude:
  • Structural abnormalities (mitral valve disease, congenital defects like ASD)
  • Tachycardia-mediated cardiomyopathy (occurs in ~1% but reversible with rhythm control) 3, 2, 4
  • This determines medication safety (particularly class IC agents)

Acute Management (If Presenting During Episode)

Hemodynamically Stable Patients

1. Vagal maneuvers first 1, 2:

   • Modified Valsalva (bearing down 10-30 seconds at 30-40 mmHg): ~43% effective
   • Ice-cold wet towel to face
   • Carotid massage (after confirming no bruit): 5-10 seconds
   • Avoid eyeball pressure—dangerous and abandoned

2. Adenosine 6-12 mg IV if vagal maneuvers fail 1, 3, 2:

   • 91% effective for terminating SVT
   • Critical caveat: Have cardioversion available—adenosine can precipitate atrial fibrillation that may conduct rapidly if pre-excitation present
   • Expect brief side effects in ~30% (flushing, chest discomfort, dyspnea—all <1 minute)
   • Post-conversion extrasystoles are common and may re-trigger tachycardia 1

3. Alternative pharmacologic options (if adenosine contraindicated):

   • IV diltiazem, verapamil, or beta-blockers: 80-98% success rate 1
   • Only if no pre-excitation on baseline ECG—these are potentially harmful in WPW 1

Hemodynamically Unstable Patients

• Immediate synchronized cardioversion 1
• Do not delay for pharmacologic therapy

Long-Term Management for Recurrent Episodes

First-Line: Catheter Ablation

Catheter ablation is recommended as first-line definitive therapy for recurrent symptomatic SVT 1, 2:

• Success rates: 93-98.5% with single procedure 1, 2
• Major complication risk: ~3% 1
• Particularly appropriate for this patient given:
  • Recurrent symptomatic episodes
  • Reduced quality of life from repeated episodes 3, 2
  • Curative intent vs. lifelong medication

Alternative: Pharmacologic Therapy

If patient declines ablation or is not a candidate:

Without pre-excitation (concealed pathway):

• Beta-blockers, diltiazem, or verapamil: ~50% effective for preventing recurrence 1
• Favorable side effect profile

With pre-excitation on resting ECG:

• Flecainide or propafenone (if no structural/ischemic heart disease): 85-90% effective 1

  • 30% become arrhythmia-free
  • Contraindicated with structural heart disease due to proarrhythmia risk
  • Side effects in 60%, 20% discontinue

• Sotalol or dofetilide: Can use with structural heart disease 1

  • Require inpatient initiation with ECG monitoring (QT prolongation/torsades risk)

• Amiodarone: Reserved for refractory cases due to long-term toxicity 1

Critical Pitfalls to Avoid

1. Never give AV nodal blockers (digoxin, amiodarone, beta-blockers, calcium channel blockers) if pre-excited atrial fibrillation is present—these can accelerate ventricular rate and cause ventricular fibrillation 1

2. Always have cardioversion available when giving adenosine—can precipitate rapidly-conducted AF 1

3. Don't use class IC agents (flecainide/propafenone) if structural heart disease present—increased VT risk 1

4. Consider hormonal triggers: This patient's recurrent episodes may correlate with menstrual cycle (estrogen/progesterone fluctuations affect arrhythmia susceptibility) 3

5. Post-conversion extrasystoles commonly re-trigger tachycardia—may need antiarrhythmic to prevent immediate recurrence 1